CSS
RXST icon

Cubist Systematic Strategies’s RxSight RXST Stock Holding History

Cubist Systematic Strategies’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,000
Closed -$481K – 3436
2024
Q2 		$481K Buy
+8,000
New +$457K ﹤0.01% 2151

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cubist Systematic Strategies's RXST Position: Q3 2025 in Review

Cubist Systematic Strategies increased its RxSight (RXST) stake by 258% in Q3 2025, buying an estimated $926K and bringing the position to 146,406 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #1813.

Cubist Systematic Strategies first reported a position in RXST in Q3 2022 and has held it in 13 quarters since. The position peaked at $8.42M in Q1 2025. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

  • Cubist Systematic Strategies held 146,406 shares of RxSight worth $1.32M as of Q3 2025.
  • Cubist Systematic Strategies bought 105,505 RxSight shares in Q3 2025, an estimated $926K.
  • RxSight made up 0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1813 holding.
  • Cubist Systematic Strategies first reported a position in RxSight in Q3 2022 and has held it in 13 quarters since.
  • Cubist Systematic Strategies's RxSight position peaked at $8.42M in Q1 2025.
  • 160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.